Vodicka P, Benesova K, Janikova A, Prochazka V, et al. Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world. Eur J Haematol 2022 May 3. doi: 10.1111/ejh.13784.
PMID: 35502609